17 March, 2021 in Healthcare, Study / 0 Comments ISSUE BRIEF: ICER Analyses Are Flawed, Undervalue Life-Saving Medicines, and Are Biased Toward Price Controls
17 February, 2021 in Business Economics, Featured Business Economics, Pri Press Releases, Study / 0 Comments NEW STUDY: Rejecting Push to Restrict Gig Entrepreneurship Key to Driving Innovation, Economic Growth, Higher Incomes
13 May, 2020 in California, Environment, Study / 0 Comments NEW STUDY: Californians Could Save More Than $2,000 Annually if Lawmakers Enacted Free-Market Energy Policies
05 November, 2019 in Business Economics, Pri Press Releases / 0 Comments Wayne Winegarden quoted in Washington Examiner on trade wars
05 September, 2019 in Commentary, Healthcare / 0 Comments Defining a Medicines’ Value versus its Price
12 June, 2019 in Healthcare, Study / 0 Comments Much-Publicized Report on Financial Returns on Cancer Treatments Contains Significant Flaws and Biases, Finds New PRI Brief
22 May, 2019 in Business Economics, Study / 0 Comments New Study Finds ESG Funds Underperform Broader Investment Funds Over Long-Term
03 April, 2019 in Blog, Business Economics, Study / 0 Comments NEW STUDY: Costly Regulations Hurt Entrepreneurship, Reform Needed to ‘Break Down Barriers’ for Jobs, Innovation
08 October, 2018 in Healthcare, Study / 0 Comments New PRI Study: Congress Has Some Unfinished Business – Acting to Repeal the Medical Device Tax
16 May, 2017 in Business Economics, Healthcare, Study / 0 Comments New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs
